{{Rsnum
|rsid=12632942
|Gene=SCN10A
|Chromosome=3
|position=38723507
|Orientation=plus
|GMAF=0.2378
|Gene_s=SCN10A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 54.9 | 41.6 | 3.5
| HCB | 31.4 | 54.0 | 14.6
| JPT | 30.4 | 54.5 | 15.2
| YRI | 78.9 | 21.1 | 0.0
| ASW | 70.2 | 28.1 | 1.8
| CHB | 31.4 | 54.0 | 14.6
| CHD | 37.6 | 45.0 | 17.4
| GIH | 58.4 | 34.7 | 6.9
| LWK | 85.5 | 14.5 | 0.0
| MEX | 77.6 | 20.7 | 1.7
| MKK | 76.3 | 19.2 | 4.5
| TSI | 53.9 | 40.2 | 5.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24072447
|Title=Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation
}}

{{PMID Auto
|PMID=20062060
|Title=Genome-wide association study of PR interval.
|OA=1
}}

{{PMID Auto
|PMID=23821303
|Title=Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}